Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53676

1.

Breast cancer prevention in the era of precision medicine.

Narod SA.

J Natl Cancer Inst. 2015 Apr 8;107(5). pii: djv078. doi: 10.1093/jnci/djv078. Print 2015 May. No abstract available.

PMID:
25855708
2.

Prediction of breast cancer risk based on profiling with common genetic variants.

Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW, Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler RK, Sutter C, Yang R, Schürmann P, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Guénel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Brauch H, Brüning T, Ko YD, Sigurdson AJ, Doody MM, Hamann U, Torres D, Ulmer HU, Försti A, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Glendon G, Marie Mulligan A, Chenevix-Trench G, Balleine R, Giles GG, Milne RL, McLean C, Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AM, Koppert LB, Carpenter J, Clarke C, Scott R, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Brenner H, Arndt V, Stegmaier C, Karina Dieffenbach A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Offit K, Vijai J, Robson M, Rau-Murthy R, Dwek M, Swann R, Annie Perkins K, Goldberg MS, Labrèche F, Dumont M, Eccles DM, Tapper WJ, Rafiq S, John EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S, Zheng W, Halverson SL, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M.

J Natl Cancer Inst. 2015 Apr 8;107(5). pii: djv036. doi: 10.1093/jnci/djv036. Print 2015 May.

3.

A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer.

Delahaye-Sourdeix M, Anantharaman D, Timofeeva MN, Gaborieau V, Chabrier A, Vallée MP, Lagiou P, Holcátová I, Richiardi L, Kjaerheim K, Agudo A, Castellsagué X, Macfarlane TV, Barzan L, Canova C, Thakker NS, Conway DI, Znaor A, Healy CM, Ahrens W, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Fabianova E, Mates IN, Bencko V, Foretova L, Janout V, Curado MP, Koifman S, Menezes A, Wünsch-Filho V, Eluf-Neto J, Boffetta P, Fernández Garrote L, Polesel J, Lener M, Jaworowska E, Lubiński J, Boccia S, Rajkumar T, Samant TA, Mahimkar MB, Matsuo K, Franceschi S, Byrnes G, Brennan P, McKay JD.

J Natl Cancer Inst. 2015 Apr 2;107(5). pii: djv037. doi: 10.1093/jnci/djv037. Print 2015 May.

4.

[Chymotripsin-like activity and subunit composition of proteasomes in human cancers].

Kondakova IV, Spirina LV, Koval VD, Shashova EE, Choinzonov EL, Ivanova EV, Kolomiets LA, Chernyshova AL, Slonimskaya EM, Usynin EA, Afanasyev SG.

Mol Biol (Mosk). 2014 May-Jun;48(3):444-51. Russian.

PMID:
25831894
5.

Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

Rae JM, Leyland-Jones B, Regan M, Thompson AM.

J Natl Cancer Inst. 2015 Mar 26;107(5). pii: djv065. doi: 10.1093/jnci/djv065. Print 2015 May. No abstract available.

PMID:
25814445
6.

[The drug of the month: everolimus (Afinitor) for the treatment of metastatic breast cancer].

Jerusalem G, Rorive A, Collignon J.

Rev Med Liege. 2014 Sep;69(9):510-7. Review. French.

PMID:
25796760
7.

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.

Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, Ausems MG, Collée JM, van Doorn HC, Gomez Garcia EB, Kets CM, van Leeuwen FE, Meijers-Heijboer HE, Mourits MJ, van Os TA, Vasen HF, Verhoef S, Rookus MA, Hooning MJ; Hereditary Breast and Ovarian Cancer Research Group Netherlands.

J Natl Cancer Inst. 2015 Mar 18;107(5). pii: djv033. doi: 10.1093/jnci/djv033. Print 2015 May.

PMID:
25788320
8.

A 12-year experience at a tertiary hospital on patients with multiple primary malignant neoplasms.

Papaconstantinou I, Mantzos DS, Asimakoula K, Michalaki V, Kondi-Pafiti A.

J BUON. 2015 Jan-Feb;20(1):332-7.

PMID:
25778335
9.
10.

Protein stability versus function: effects of destabilizing missense mutations on BRCA1 DNA repair activity.

Gaboriau DC, Rowling PJ, Morrison CG, Itzhaki LS.

Biochem J. 2015 Mar 15;466(3):613-24. doi: 10.1042/BJ20141077.

PMID:
25748678
11.

The contributions of breast density and common genetic variation to breast cancer risk.

Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ.

J Natl Cancer Inst. 2015 Mar 4;107(5). pii: dju397. doi: 10.1093/jnci/dju397. Print 2015 May.

PMID:
25745020
12.

[The Supreme Court free genes - economic and legal justifications - impacts on innovation and the healthcare offer].

Cassier M, Stoppa-Lyonnet D.

Med Sci (Paris). 2015 Feb;31(2):209-13. doi: 10.1051/medsci/20153102019. Epub 2015 Mar 4. French. No abstract available.

PMID:
25744269
13.

[Digital PCR compartmentalization II. Contribution for the quantitative detection of circulating tumor DNA].

Caen O, Nizard P, Garrigou S, Perez-Toralla K, Zonta E, Laurent-Puig P, Taly V.

Med Sci (Paris). 2015 Feb;31(2):180-6. doi: 10.1051/medsci/20153102015. Epub 2015 Mar 4. Review. French.

PMID:
25744265
14.

Case series: five individuals diagnosed with breast and gastrointestinal cancers: are they "related"?

McFarland D, Miller-Samuel S, Schmidt H, Morris GJ.

Semin Oncol. 2015 Feb;42(1):e1-12. doi: 10.1053/j.seminoncol.2014.12.016. Epub 2014 Dec 9. No abstract available.

PMID:
25726062
15.

RE: How many etiological subtypes of breast cancer: two, three, four, or more?

Caldarella A, Crocetti E.

J Natl Cancer Inst. 2015 Feb 24;107(4). pii: djv031. doi: 10.1093/jnci/djv031. Print 2015 Apr. No abstract available.

PMID:
25717173
16.

Response.

Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME.

J Natl Cancer Inst. 2015 Feb 24;107(4). pii: djv029. doi: 10.1093/jnci/djv029. Print 2015 Apr. No abstract available.

PMID:
25717172
17.

RE: How many etiological subtypes of breast cancer: two, three, four, or more?

Lawson JS.

J Natl Cancer Inst. 2015 Feb 24;107(4). pii: djv028. doi: 10.1093/jnci/djv028. Print 2015 Apr. No abstract available.

PMID:
25717171
18.

Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.

Ng CK, Schultheis AM, Bidard FC, Weigelt B, Reis-Filho JS.

J Natl Cancer Inst. 2015 Feb 23;107(5). pii: djv015. doi: 10.1093/jnci/djv015.

PMID:
25713166
19.

Dual HER2 gene protein assay: focused study of breast cancers with 2+ immunohistochemical expression.

Li Z, Dabbs DJ, Cooper KL, Bhargava R.

Am J Clin Pathol. 2015 Mar;143(3):451-8. doi: 10.1309/AJCPKIVVW4OBPX6I.

PMID:
25696805
20.

Metaplastic breast carcinoma: more than a special type.

Weigelt B, Eberle C, Cowell CF, Ng CK, Reis-Filho JS.

Nat Rev Cancer. 2014 Mar;14(3):147-8.

PMID:
25688406
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk